I reckon (as Cort suggests) this move from VIPdx is linked to the CDC's upcoming meeting/annoucement. Cynic as I am (from experience) it would be wise for VIPdx to announce the test prematurely, to counter the inevitable fall out from the ME CFS community finding out the CDC may well be planning on brushing XMRV aside and in doing so not protecting the blood supply. Worse still not bothering to do a Replication Study at all- due to political reasons. As has happened so far 8 months since the public annoucement of XMRV in CFS. Something which is inexcusable, and repeating the CDC's history of managing 'Gay Flu'. Thus............................................... Realistic Scenario Fantasy 1: 1) New Serology test from VIPdx, possibly 2 new? (Elisa & Western Blot). 2) Culture test licensed for Europe @ Redlabs (Probably too much to expect more than 1 test at the moment). That would be pretty major as Europe hasn't got a test, and European population is 57% bigger than the USA. (That's a vast amount of people who need to be tested). Possible Scenario Fantasy 2: more than Belgium gets VIPdx/WPI XMRV technology, under license and multiple countries announced. E.g. Canada, Australia, Germany etc. Once that happens, the amout of patients (and familes - e.g moms) finding out they are XMRV+ (CFS, Healthy, Autistic) will hit the roof - forcing the CDC to change policy around late 2011/2012 . This may come in time and is vital in the disinformation war. Unrealistic Scenario Fantasy 3: VIPdx (to the irritation of the CDC) VIPdx announce CDC found XMRV in their fatigue critera CFS using WPI licensed blood tests and now publically tell CDC on their website they must now do a replication study as the public are at risk.